The KC1 subtype exhibited prominent activation of the SPP1 and CRH pathways, aligning with established roles of the CXCL9‐SPP1 macrophage polarity axis in promoting tumour progression and immunotherapy resistance.50 Here, SPP1 is linked to neoplasm.